Ian Ratcliffe
QuietNamed in filings at Sands Capital Ventures
- Board seats filed
- 10
Named in filings at Sands Capital Ventures
all filings on record
last 24 months
from a verified or cited source
| VITARA BIOMEDICAL | Not yet classified | July 2022 | First Spark Ventures |
| SCM-S72-1 | Not yet classified | August 2019 | None on file |
| TECKRO | Not yet classified | December 2018 | None on file |
| NanoView Biosciences | Not yet classified | September 2018 | None on file |
| Avitide | Biotech & pharma | June 2017 | 82vs, Borealis, Omega Funds, SV Life Sciences |
| Acessa Health | Medical devices | June 2017 | None on file |
| Agilis Biotherapeutics | Not yet classified | February 2017 | None on file |
| Mitra RxDx | Biotech & pharma | August 2016 | Accel, Accel India |
| FreshAir Sensor | Not yet classified | January 2016 | None on file |
| Stemgent | Biotech & pharma | January 2012 | None on file |
The company and date are what the SEC filing shows, not a statement of investment thesis. A partner can sit on a board for reasons that say nothing about what their firm funds today. The category is not a filing value: it is Lev’s own classification of each company, shown only when we found a specific, checkable source for it; otherwise it reads “Not yet classified.” “Also on the board from” names another tracked firm with a partner on the same board, both with a clean identity match. It is not a claim either firm led or co-led the round, and “None on file” means no other tracked firm’s partner shares this specific board seat, not that no one else invested. Sorted newest first by default; click a column to change it. Something wrong? Tell us.
Categories of companies where filings name Ian Ratcliffe on the board, based on 4 filed seats with a verified or cited source.
6 more filed seats not yet classified, left out of the shares above.